ArticleWorld journal of gastrointestinal oncology2025
Metastasizing to the colon from triple-negative breast cancer: A case report and review of literature.
Article in World journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Colonic metastasis from breast carcinoma: A case report and systematic review of a rare clinical scenario.International journal of colorectal disease · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast cancer (BC) metastasis to the gastrointestinal tract is uncommon, colonic metastasis from BC (CMBC) is even rarer. CASE SUMMARY: This report describes a 44-year-old female patient with metastatic triple-negative BC in the ascending colon who underwent laparoscopic radical right hemicolectomy. The patient had undergone left modified radical mastectomy only 15 months ago and stopped chemotherapy just 3 months ago. The diagnosis of CMBC was made based on the previous history of BC and positive results of several specific immunohistochemical markers (gross cystic disease fluid protein 15, mammaglobin, GATA-binding protein 3, and cytokeratin 7) for breast carcinoma.
conclusionCMBC should be highly cautious in patients with a previous history of BC, especially triple-negative BC, and further examination to aid in diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.